2 weeks Ago By Defense World Staff
Tempus AI ( NASDAQ:TEM – Get Free Report ) was downgraded by Stifel Nicolaus from a “buy” rating to a “hold” rating in a report issued on Monday, MarketBeat.com reports. They currently have a $65.
00 price objective on the stock, up from their previous price objective of $45.00. Stifel Nicolaus’ price target would suggest a potential downside of 4.
47% from the company’s previous close. A number of other analysts have also weighed in on TEM. Bank of America lowered shares of Tempus AI from a “buy” rating to a “neutral” rating and upped their target price for the stock from $45.
00 to $60.00 in a research note on Wednesday, October 2nd. JPMorgan Chase & Co.
lifted their price objective on shares of Tempus AI from $42.00 to $47.00 and gave the stock an “overweight” rating in a research report on Wednesday, August 7th.
Needham & Company LLC reissued a “buy” rating and issued a $47.00 target price on shares of Tempus AI in a report on Wednesday, August 7th. Piper Sandler initiated coverage on Tempus AI in a report on Monday, August 12th.
They set a “neutral” rating and a $40.00 price target for the company. Finally, Loop Capital increased their price objective on Tempus AI from $48.
00 to $57.00 and gave the company a “buy” rating in a report on Tuesday, October 15th. Three investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock.
According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $54.22. Check Out Our Latest Stock Analysis on TEM Tempus AI Trading Down 12.
3 % Institutional Inflows and Outflows A number of institutional investors have recently bought and sold shares of TEM. First Horizon Advisors Inc. purchased a new position in shares of Tempus AI in the 3rd quarter valued at approximately $30,000.
Sumitomo Mitsui Trust Group Inc. lifted its holdings in shares of Tempus AI by 1,591.2% during the third quarter.
Sumitomo Mitsui Trust Group Inc. now owns 1,217,699 shares of the company’s stock worth $68,922,000 after purchasing an additional 1,145,698 shares during the period. GSA Capital Partners LLP acquired a new position in Tempus AI in the 3rd quarter valued at $306,000.
Sigma Planning Corp purchased a new position in Tempus AI during the 3rd quarter worth $1,323,000. Finally, ARK Investment Management LLC lifted its stake in shares of Tempus AI by 355.0% in the 3rd quarter.
ARK Investment Management LLC now owns 2,378,157 shares of the company’s stock worth $134,604,000 after acquiring an additional 1,855,459 shares during the period. About Tempus AI ( Get Free Report ) Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.
See Also Five stocks we like better than Tempus AI Stock Market Sectors: What Are They and How Many Are There? Home Depot Stock: Targeting 12% in 2024 and 25% More in 2025 How to Calculate Stock Profit Is Tesla’s Valuation a Bubble or Backed by Real Growth? How to buy stock: A step-by-step guide for beginners Trucking Stocks Led the Pack Last Week: Can They Keep Rolling? Receive News & Ratings for Tempus AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tempus AI and related companies with MarketBeat.com's FREE daily email newsletter ..
